Non-AURKA mRNAs with partial complementarity

Non-AURKA mRNAs with partial complementarity represent a category of off-target transcripts that are inadvertently affected by RNA-based therapeutics designed to target Aurora Kinase A (AURKA). This interaction typically occurs when an siRNA or antisense oligonucleotide (ASO) possesses a sequence, often within the 'seed region,' that is complementary to sequences found in mRNAs other than the intended AURKA target (Jackson et al., 2003, Nature Biotechnology). Such binding can trigger the RNA-induced silencing complex (RISC) or RNase H-mediated degradation, leading to the downregulation of proteins essential for normal cellular function (Birmingham et al., 2006, Nature Methods). This phenomenon is a major challenge in the development of oligonucleotide therapies, as it can result in unpredictable toxicities and narrow the therapeutic window. In the context of cancer treatment, off-target silencing of tumor suppressors or housekeeping genes could lead to adverse phenotypic changes. Therefore, rigorous bioinformatic screening and chemical modifications are employed during drug design to minimize these unintended interactions.

Other names

Off-target mRNA transcriptsSeed-sequence matched mRNAsNon-specific RNAi targetsCross-reactive mRNA species

Unintended sequence-specific binding leading to degradation or translational inhibition of non-target transcripts via RNA interference or antisense mechanisms.